Prognostic value and clinical pathology of MACC-1 and c-MET expression in gastric carcinoma

Pathology and Oncology Research

Volumn 19, Issue 4, 2013, Pages 821-832

  Ma, Jie ^a   Ma, Jun ^b   Meng, Qun ^a   Zhao, Zhong Sheng ^a   Xu, Wen Juan ^a  

^a ZHEJIANG PROVINCIAL PEOPLE'S HOSPITAL   (China)

^b GongShu District People's Hospital   (China)

Author keywords

c MET; Gastric cancer; MACC 1; Prognosis; Progression

Indexed keywords

MACC 1 PROTEIN; SCATTER FACTOR RECEPTOR; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGE; AGED; ARTICLE; BLOOD VESSEL; CANCER PROGNOSIS; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; CHINA; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; FEMALE; GENDER; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MALE; PROGNOSTIC VALUE; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CARCINOMA; STOMACH MUCOSA; TUMOR INVASION;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; CHI-SQUARE DISTRIBUTION; DISEASE PROGRESSION; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-MET; REAL-TIME POLYMERASE CHAIN REACTION; STOMACH NEOPLASMS; TRANSCRIPTION FACTORS; UP-REGULATION;

EID: 84885174908     PISSN: 12194956     EISSN: 15322807     Source Type: Journal    
DOI: 10.1007/s12253-013-9650-0     Document Type: Article

References (43)

1. Steeg PS (2006) Tumor metastasis: mechanistic insights and clinical challenges. Nat Med 12:895-904
2. Smith BR, Stabile BE (2009) Extreme aggressiveness and lethality of gastric adenocarcinoma in the very young. Arch Surg 144(6):506-10
3. Birchmeier C, Birchmeier W, Gherardi E et al (2003) Met, metastasis, motility and more. Nat Rev Mol Cell Biol 4(12):915-925
4. Okines AF, Reynolds AR, Cunningham D (2011) Targeting angiogenesis in esophagogastric adenocarcinoma. Oncologist 16(6):844-58
5. Lai L, Goldschneider I (2001) Cutting edge: identification of a hybrid cytokine consisting of IL-7 and the beta-chain of the hepatocyte growth consisting of IL-7 and the beta-chain of the hepatocyte growth factor/scatter factor. Immun 167:3550-3554
6. Stein U, Ahher W, Arlt F et al (2009) MACC1, a newly identifiedkey regulator of HGF-MET signaling, predicts colon cancermetastasis. Nat Med 15(1):59-67
7. Lee HS, Lee HK, Kim HS, Yang HK, Kim WH (2003) Tumour suppressor gene expression correlates with gastric cancer prognosis. J Pathol 200:39-46
8. Lee HS, Lee HK, Kim HS, Yang HK, Kim YI, Kim WH (2001) MUC1, MUC2, MUC5AC, and MUC6 expressions in gastric carcinomas: their roles as prognostic indicators. Cancer 92:1427-34
9. Zhang D, Salto-Tellez M, Putti TC, Do E, Koay ES (2003) Reliability of tissue microarrays in detecting protein expression and gene amplification in breast cancer. Mod Pathol 16:79-84
10. Lee HS, Cho SB, Lee HE et al (2007) Protein expression profiling and molecular classification of gastric cancer by the tissue array method. Clin Cancer Res 13(14):4154-63
11. Mizokami K, Kakeji Y, Oda S et al (2006) Clinicopathologic significance of hypoxia-inducible factor 1 alpha overexpression in gastric carcinomas. J Surg Oncol 94:149-154
12. Song LB, Liao WT, Mai HQ et al (2006) The clinical significance of twist expression in nasopharyngeal carcinoma. Cancer Lett 242:258-65
13. Kolev Y, Uetake H, Iida S, Ishikawa T, Kawano T, Sugihara K (2007) Prognostic significance of VEGF expression in correlation with COX-2, microvessel density, and clinicopathological characteristics in human gastric carcinoma. Ann Surg Oncol 14(10):2738-47
14. Xu ZY, Chen JS, Shu YQ (2010) Gene expression profile towards the prediction of patient survival of gastric cancer. Biomed Pharmacother 64(2):133-9
15. Weidner KM, Arakaki N, Hartmann G et al (1991) Evidence for the identity of human scatter factor and human hepatocyte growth factor. Proc Nat Acad Sci USA 88:7001-7005
16. Sierra JR, Tsao MS (2011) c-MET as a potential therapeutic target and biomarker in cancer. Ther Adv Med Oncol 3(1 Suppl):S21-35
17. Galimi F, Torti D, Sassi F et al (2011) Genetic and expression analysis of MET, MACC1, and HGF in metastatic colorectal cancer: response to met inhibition in patient xenografts and pathologic correlations. Clin Cancer Res 17(10):3146-56
18. Arlt F, Stein U (2009) Colon cancer metastasis: MACC1 and Met as metastatic pacemakers. Int J Biochem Cell Biol 41(12):2356-9
19. Kokoszyńska K, Kryński J, Rychlewski L et al (2009) Unexpected domain composition of MACC1 links MET signaling and apoptosis. Acta Biochim Pol 56(2):317-23
20. Lang AH, Geller-Rhomberg S, Winder T et al (2012) A common variant of the MACC1 gene is significantly associated with overall survival in colorectal cancer patients. BMC Cancer 12(1):20
21. Stein U, Dahlmann M, Walther W (2010) MACC1 - more than metastasis? Facts and predictions about a novel gene. J Mol Med (Berl) 88(1):11-8
22. Qiu J, Huang P, Liu Q, Hong J, Li B, Lu C, Wang L, Wang J, Yuan Y (2011) Identification of MACC1 as a novel prognostic marker in hepatocellular carcinoma. J Transl Med 9:166
23. Chundong G, Uramoto H, Onitsuka T et al (2011) Molecular diagnosis of MACC1 status in lung adenocarcinoma by immunohistochemical analysis. Anticancer Res 31(4):1141-5
24. Aoba-ku Y (2010) MACC 1 as a marker for peritoneal-disseminated gastric carcinoma. Anticancer Res 30:3441-3444
25. Zhang R, Shi H, Chen Z et al (2011) Effects of metastasis-associated in colon cancer 1 inhibition by small hairpin RNA on ovarian carcinoma OVCAR-3 cells. J Exp Clin Cancer Res 30:83
26. Shirahata A, Shinmura K, Kitamura K et al (2010) MACC 1 as a marker for advanced colorectal carcinoma. Anticancer Res 30:3441-3444
27. Boardman LA (2009) Overexpression of MACC1 leads to downstream activation of HGF/MET and potentiates metastasisand recurrence of colorectal cancer. Genome Med 1(4):361-364
28. Brand-Saberi B, Muller TS, Wilting J et al (1996) Scatter factor/hepatocyte growth factor (SF/HGF) induces emigration of myogenic cells at interlimb level in vivo. Dev Biol 179(1):303-8
29. Borowiak M, Garratt AN, Wustefeld T, Strehle M, Trautwein C, Birchmeier C (2004) Met provides essential signals for liver regeneration. Proc Natl Acad Sci U S A 101:10608-10613
30. Bahary N, Zon L (2001) Development. Endothelium-chicken soup forthe endoderm. Science 294(5542):530-531
31. Wu FS, Zheng SS, Wu LJ et al (2006) Study on the pregnomic value of hepatocyte growth factor and c-met for patients with hepatocellular carcinoma. Zhonghua Wai lke za zlli 44(9):603-608
32. Chen BK, Ohtsuki Y, Furihata M et al (1999) Overexpression of c-Metprotein in human thyroid tumors correlated with lymph node metastasis and clinicopathologic stage. Pathol Res Pract 195(6):427-433
33. Ghoussoub RA, Dillon DA, D'Aquila T et al (1998) Expression of c-metis a strong independent prognostic factor in breast carcinoma. Cancer 82(8):1513-1520
34. Camp RL, Rimm EB, Goedecke S et al (1999) Met expression is associated with poor outcome in patients with axillary lymph node negative breast carcinoma. Cancer 86:2259-2265
35. Zhang RT, Shi HR, Huang HL et al (2011) Expressions of MACC1, HGF, and C-met protein in epithelial ovarian cancer and their significance. Nan Fang Yi Ke Da Xue Xue Bao 31(9):1551-5
36. Di Renzo MF, Olivero M, Giacomini A et al (1995) Overexpression and amplification of the met/HGF receptor gene during the progression of colorectal cancer. Clin Cancer Res 1(2):147-54
37. Nakajima M, Sawada H, Yamada Y et al (1999) The prognostic significance of amplification and overexpression of c-met and c-erb B-2 in human gastric carcinomas. Cancer 85(9):1894-902
38. Ma PC, Jagadeeswaran R, Jagadeesh S et al (2005) Functional expression and mutations of c-Met and its therapeutic inhibition with SU11274 and small interfering RNA in non-small cell lung cancer. Cancer Res 65(4):1479-88
39. Migliore C, Martin V, Leoni VP et al (2012) MiR-1 downregulation cooperates with MACC1 in promoting MET overexpression in human colon cancer. Clin Cancer Res 18(3):737-47
40. Herynk MH, Stoeltzing O, Reinmuth N et al (2003) Down regulation of c-Met inhibits growth in the liver of human colorectal carcinoma cells. Cancer Res 63(11):2990-299
41. Date K, Matsumoto K, Kuba K et al (1998) Inhibition of tumor growth and invasion by afour-kringleantagonis t(HGF/NK4) for heap-tocyte growth factor. Oncogene 17(23):3045-3051
42. Stein U, Schlag PM (2007) Clinical, biological, and molecular aspects of metastasis in colorectalcancer. Recent Res Cancer Res 176:61-8
43. Kokoszynska K, Krynski J, Rychlewski L et al (2009) Unexpected domain composition of MACC1 links MET signaling and apoptosis. Acta Biochim Pol 56:317-323